1. bu-abdullaziz

    bu-abdullaziz عضو مميز

    التسجيل:
    ‏11 ديسمبر 2003
    المشاركات:
    1,777
    عدد الإعجابات:
    0
    يستحق المتابعه

    December 9th, 2004:


    We are profiling Arrowhead Research Corp. (ARWR) at $3.67 as a long-term strong buy.

    ARWR formerly InterActive Group, is a development-stage nanotechnology company structured to bring together a mix of technologies, rights to a broad suite of intellectual property and professionals in the field of nanotechnology.

    ARWR just announced today that it will provide approximately $100,000 in additional funding to Dr. Patrick Collier and his team of nanotech researchers at the California Institute of Technology ("Caltech") over the next four year period.

    Since September 2003, ARWR has funded research led by Dr. Collier in exchange for the option to exclusively license intellectual property generated through the research. The Collier group is developing new technologies that could enable the control of individual molecules for revolutionary devices and systems in the life sciences and electronics industries. In 2004, Collier's team filed five provisional patent applications that ARWR has the option to license.

    ARWR has exclusive rights to 33 issued U.S. patents and, in total, over 180 U.S. and international patents and patent applications.

    A recent report from CHI Research said, "In general, it appears that Arrowhead's nanotechnology IP already locks up, or is well on the way to locking up, those areas of nanotechnology that it has set out to control. Furthermore, we find that Arrowhead's entire nanotechnology patent portfolio is more broadly distributed across invention art classifications than that of its main competitors. In other words, among its main competitors, Arrowhead has the most diversified portfolio of patents in the nanotechnology space."

    ARWR has three majority-owned subsidiary companies: Aonex Technologies, Inc., developing and commercializing semiconductor nanomaterial technology. Insert Therapeutics, Inc. which is developing and commercializing a proprietary drug delivery system. Nanotechnica, Inc., formed to develop capabilities for mass-production of a variety of different nanoscale devices and systems.

    ARWR appears to be undiscovered by the investment and could have significant upside potential.


    مع تحيات

    Lebed.biz
     
  2. bu-abdullaziz

    bu-abdullaziz عضو مميز

    التسجيل:
    ‏11 ديسمبر 2003
    المشاركات:
    1,777
    عدد الإعجابات:
    0
    حركته خطيره جدا

    شوفوا الجارت وصل الى 4.14 و ارتد بقوه الى 4 :mad:
     

    الملفات المرفقة:

    • arwr.JPG
      arwr.JPG
      حجم الملف:
      25.7 KB
      المشاهدات:
      79
  3. bu-abdullaziz

    bu-abdullaziz عضو مميز

    التسجيل:
    ‏11 ديسمبر 2003
    المشاركات:
    1,777
    عدد الإعجابات:
    0